{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:09:46Z","timestamp":1784052586941,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Instituto de Investigaciones Biom\u00e9dicas de Barcelona"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Current acute ischemic stroke treatment is limited to reperfusion therapies within the first hours after the onset, underscoring the urgent need for novel therapeutic strategies to mitigate the progression of the brain lesion. Here, we describe the development of bio-inspired synthetic nanoshuttles\u2014lipid nanoparticles (LNPs)\u2014designed to deliver miRNAs and target post-stroke inflammation, a key contributor to secondary brain damage. miRNAs isolated from human induced pluripotent stem cells (hiPSCs) were encapsulated into LNPs prepared by a microfluidic technique. We produced small sized, uniform nanoparticles with high miRNA encapsulation efficiency. LNPs were functionalized with anti-transferrin receptor (TfR) and anti-E-selectin antibodies to target the inflamed cerebral vasculature. We assayed LNPs\u2019 effect in a model of vascular inflammation in vitro and in vivo following brain ischemia\/reperfusion in mice. In cultured human brain endothelial cells, empty LNPs, dual-targeted empty LNPs, and dual-targeted LNP encapsulating miRNAs (DT-LNP) reduced lipopolysaccharide-induced interleukin-6 production, indicating a modulatory effect of the lipid carrier under our experimental conditions. Mice received, via i.v., either empty LNPs (control) or two different doses of DT-LNPs at reperfusion following brain ischemia. The low dose of DT-LNPs reduced infarct volume and tended to improve the neurological deficit, and to downregulate the expression of IL-1\u03b2 and E-selectin mRNAs, whereas the high dose did not. Altogether, these findings provide proof-of-concept that TfR-E-selectin-targeted LNPs encapsulating hiPSC-derived miRNAs represent a promising therapeutic approach for stroke.<\/jats:p>","DOI":"10.1007\/s13346-026-02185-8","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:42:05Z","timestamp":1784050925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["E-selectin and transferrin receptor functionalized synthetic miRNA nanoshuttles with therapeutic potential in stroke"],"prefix":"10.1007","author":[{"given":"Val\u00e9rie","family":"Petegnief","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kannavou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Peli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Justicia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini","family":"Gkartziou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Aliena-Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan B.","family":"Salom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorian","family":"Tace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Planas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia G.","family":"Antimisiaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Lazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"4","key":"2185_CR1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13311-016-0483-x","volume":"13","author":"J Anrather","year":"2016","unstructured":"Anrather J, Iadecola C. Inflammation and stroke: an overview. Neurotherapeutics. 2016;13(4):661\u201370. https:\/\/doi.org\/10.1007\/s13311-016-0483-x.","journal-title":"Neurotherapeutics"},{"key":"2185_CR2","doi-asserted-by":"publisher","unstructured":"Gorey S, McCabe JJ, Kelly PJ. Inflammation\u2014The new treatment target for ischaemic stroke prevention. Frontiers in Stroke. 2023; 2. https:\/\/doi.org\/10.3389\/fstro.2023.1241506","DOI":"10.3389\/fstro.2023.1241506"},{"issue":"6","key":"2185_CR3","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/glia.24501","volume":"72","author":"AM Planas","year":"2024","unstructured":"Planas AM. Role of microglia in stroke. Glia. 2024;72(6):1016\u201353. https:\/\/doi.org\/10.1002\/glia.24501.","journal-title":"Glia"},{"issue":"11","key":"2185_CR4","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S1474-4422(19)30078-X","volume":"18","author":"K Shi","year":"2019","unstructured":"Shi K, Tian D-C, Li Z-G, Ducruet AF, Lawton MT, Shi F-D. Global brain inflammation in stroke. Lancet Neurol. 2019;18(11):1058\u201366. https:\/\/doi.org\/10.1016\/S1474-4422(19)30078-X.","journal-title":"Lancet Neurol"},{"issue":"1","key":"2185_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12974-023-02888-6","volume":"20","author":"M Arbaizar-Rovirosa","year":"2023","unstructured":"Arbaizar-Rovirosa M, Gallizioli M, Lozano JJ, Sidorova J, Pedragosa J, Figuerola S, et al. Transcriptomics and translatomics identify a robust inflammatory gene signature in brain endothelial cells after ischemic stroke. J Neuroinflamm. 2023;20(1):207. https:\/\/doi.org\/10.1186\/s12974-023-02888-6.","journal-title":"J Neuroinflamm"},{"key":"2185_CR6","doi-asserted-by":"publisher","unstructured":"Cai X, Drummond CJ, Zhai J, Tran N. Lipid nanoparticles: versatile drug delivery vehicles for traversing the blood brain barrier to treat brain cancer. Adv Funct Mater. 2024;34(41). https:\/\/doi.org\/10.1002\/adfm.202404234.","DOI":"10.1002\/adfm.202404234"},{"issue":"1","key":"2185_CR7","doi-asserted-by":"publisher","first-page":"102131","DOI":"10.1016\/j.omtn.2024.102131","volume":"35","author":"P Cepparulo","year":"2024","unstructured":"Cepparulo P, Cuomo O, Campani V, Vinciguerra A, Sisalli MJ, Nele V, et al. Anti-miRNA103\/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage. Mol Therapy - Nucleic Acids. 2024;35(1):102131. https:\/\/doi.org\/10.1016\/j.omtn.2024.102131.","journal-title":"Mol Therapy - Nucleic Acids"},{"issue":"5","key":"2185_CR8","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.ymthe.2024.03.004","volume":"32","author":"J Nong","year":"2024","unstructured":"Nong J, Glassman PM, Shuvaev VV, Reyes-Esteves S, Descamps HC, Kiseleva RY, et al. Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke. Mol Ther. 2024;32(5):1344\u201358. https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.004.","journal-title":"Mol Ther"},{"key":"2185_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejps.2017.03.010","volume":"102","author":"K Papadia","year":"2017","unstructured":"Papadia K, Giannou AD, Markoutsa E, Bigot C, Vanhoute G, Mourtas S, et al. Multifunctional LUV liposomes decorated for BBB and amyloid targeting - B. In vivo brain targeting potential in wild-type and APP\/PS1 mice. Eur J Pharm Sci. 2017;102:180\u20137. https:\/\/doi.org\/10.1016\/j.ejps.2017.03.010.","journal-title":"Eur J Pharm Sci"},{"key":"2185_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejps.2017.02.019","volume":"101","author":"K Papadia","year":"2017","unstructured":"Papadia K, Markoutsa E, Mourtas S, Giannou AD, La Ferla B, Nicotra F, et al. Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept. Eur J Pharm Sci. 2017;101:140\u20138. https:\/\/doi.org\/10.1016\/j.ejps.2017.02.019.","journal-title":"Eur J Pharm Sci"},{"issue":"15","key":"2185_CR11","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.7150\/ijbs.100113","volume":"20","author":"M Barilani","year":"2024","unstructured":"Barilani M, Peli V, Manzini P, Pistoni C, Rusconi F, Pinatel EM, et al. Extracellular vesicles from human induced pluripotent stem cells exhibit a unique MicroRNA and CircRNA signature. Int J Biol Sci. 2024;20(15):6255\u201378. https:\/\/doi.org\/10.7150\/ijbs.100113.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"2185_CR12","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.3390\/ijms25126297","volume":"25","author":"CD Maida","year":"2024","unstructured":"Maida CD, Norrito RL, Rizzica S, Mazzola M, Scarantino ER, Tuttolomondo A. Molecular Pathogenesis of ischemic and hemorrhagic strokes: background and therapeutic approaches. Int J Mol Sci. 2024;25(12):6297. https:\/\/doi.org\/10.3390\/ijms25126297.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2185_CR13","doi-asserted-by":"publisher","first-page":"e58039","DOI":"10.1371\/journal.pone.0058039","volume":"8","author":"G Pandi","year":"2013","unstructured":"Pandi G, Nakka VP, Dharap A, Roopra A, Vemuganti R. MicroRNA miR-29c down-regulation leading to De-repression of its target DNA methyltransferase 3a promotes ischemic brain damage. PLoS ONE. 2013;8(3):e58039. https:\/\/doi.org\/10.1371\/journal.pone.0058039.","journal-title":"PLoS ONE"},{"key":"2185_CR14","doi-asserted-by":"publisher","unstructured":"Gkartziou F, Petegnief V, Kannavou M, Flavi\u00e1n-L\u00e1zaro AC, Pascual N, Marquez-Kisinousky L, et al. Development of immunoliposomes with E-Selectin affinity to target endothelial inflammation: direct comparison of antibody types. J Liposome Res. 2026;1\u201313. https:\/\/doi.org\/10.1080\/08982104.2026.2645864.","DOI":"10.1080\/08982104.2026.2645864"},{"key":"2185_CR15","unstructured":"Bioscience - Bio-Techne Brand TA (n.d.). Preparation of MC3 Lipid Nanoparticles for RNA delivery Materials Required."},{"key":"2185_CR16","doi-asserted-by":"publisher","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","volume":"188","author":"C Hald Albertsen","year":"2022","unstructured":"Hald Albertsen C, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev. 2022;188:114416. https:\/\/doi.org\/10.1016\/j.addr.2022.114416.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"2185_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","volume":"16","author":"JA Kulkarni","year":"2021","unstructured":"Kulkarni JA, Witzigmann D, Thomson SB, Chen S, Leavitt BR, Cullis PR, et al. The current landscape of nucleic acid therapeutics. Nat Nanotechnol. 2021;16(6):630\u201343. https:\/\/doi.org\/10.1038\/s41565-021-00898-0.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"2185_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejpb.2012.02.006","volume":"81","author":"E Markoutsa","year":"2012","unstructured":"Markoutsa E, Papadia K, Clemente C, Flores O, Antimisiaris SG. Anti-A\u03b2-MAb and dually decorated nanoliposomes: Effect of A\u03b21\u201342 peptides on interaction with hCMEC\/D3 cells. Eur J Pharm Biopharm. 2012;81(1):49\u201356. https:\/\/doi.org\/10.1016\/j.ejpb.2012.02.006.","journal-title":"Eur J Pharm Biopharm"},{"key":"2185_CR19","doi-asserted-by":"publisher","unstructured":"Re F, Salvati, Sesana, Cambianica, Sancini, Masserini G, Gregori. Liposomes functionalized to overcome the blood\u2013brain barrier and to target amyloid-\u03b2 peptide: the chemical design affects the permeability across an in vitro model. Int J Nanomed. 2013;1749. https:\/\/doi.org\/10.2147\/IJN.S42783.","DOI":"10.2147\/IJN.S42783"},{"issue":"2","key":"2185_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejpb.2010.11.015","volume":"77","author":"E Markoutsa","year":"2011","unstructured":"Markoutsa E, Pampalakis G, Niarakis A, Romero IA, Weksler B, Couraud P-O, et al. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC\/D3 cell line. Eur J Pharm Biopharm. 2011;77(2):265\u201374. https:\/\/doi.org\/10.1016\/j.ejpb.2010.11.015.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"2185_CR21","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s11095-013-1249-3","volume":"31","author":"E Markoutsa","year":"2014","unstructured":"Markoutsa E, Papadia K, Giannou AD, Spella M, Cagnotto A, Salmona M, et al. Mono and Dually decorated nanoliposomes for brain targeting, in vitro and in vivo studies. Pharm Res. 2014;31(5):1275\u201389. https:\/\/doi.org\/10.1007\/s11095-013-1249-3.","journal-title":"Pharm Res"},{"issue":"1","key":"2185_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0003-2697(80)90269-9","volume":"104","author":"JCM Stewart","year":"1980","unstructured":"Stewart JCM. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem. 1980;104(1):10\u20134. https:\/\/doi.org\/10.1016\/0003-2697(80)90269-9.","journal-title":"Anal Biochem"},{"key":"2185_CR23","doi-asserted-by":"publisher","first-page":"102848","DOI":"10.1016\/j.ebiom.2020.102848","volume":"57","author":"M Barilani","year":"2020","unstructured":"Barilani M, Cherubini A, Peli V, Polveraccio F, Bollati V, Guffanti F, et al. A circular RNA map for human induced pluripotent stem cells of foetal origin. EBioMedicine. 2020;57:102848. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102848.","journal-title":"EBioMedicine"},{"issue":"1","key":"2185_CR24","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1038\/s41598-017-01731-2","volume":"7","author":"A Morales-Kastresana","year":"2017","unstructured":"Morales-Kastresana A, Telford B, Musich TA, McKinnon K, Clayborne C, Braig Z, et al. Labeling extracellular vesicles for nanoscale flow cytometry. Sci Rep. 2017;7(1):1878. https:\/\/doi.org\/10.1038\/s41598-017-01731-2.","journal-title":"Sci Rep"},{"key":"2185_CR25","doi-asserted-by":"publisher","unstructured":"Chaparro-Cabanillas N, Arbaizar-Rovirosa M, Salas-Perdomo A, Gallizioli M, Planas AM, Justicia C. Transient Middle Cerebral Artery Occlusion Model of Stroke. J Visualized Experiments. 2023;198. https:\/\/doi.org\/10.3791\/65857.","DOI":"10.3791\/65857"},{"issue":"3","key":"2185_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","volume":"17","author":"JB Bederson","year":"1986","unstructured":"Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17(3):472\u20136. https:\/\/doi.org\/10.1161\/01.STR.17.3.472.","journal-title":"Stroke"},{"key":"2185_CR27","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.2147\/IJN.S136426","volume":"12","author":"K Kubota","year":"2017","unstructured":"Kubota K, Onishi K, Sawaki K, Li T, Mitsuoka K, Sato T, Takeoka S. Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation. Int J Nanomed. 2017;12:5121\u201333. . https:\/\/doi.org\/10.2147\/IJN.S136426","journal-title":"Int J Nanomed"},{"issue":"12","key":"2185_CR28","doi-asserted-by":"publisher","first-page":"10430","DOI":"10.1021\/jacs.4c18308","volume":"147","author":"Y Mo","year":"2025","unstructured":"Mo Y, Keszei AFA, Kothari S, Liu H, Pan A, Kim P, Bu J, Kamanzi A, Dai DL, Mazhab-Jafari MT, Chen J, Leslie S, Zheng G. Lipid-siRNA Organization Modulates the Intracellular Dynamics of Lipid Nanoparticles. J Am Chem Soc. 2025;147(12):10430\u201345. https:\/\/doi.org\/10.1021\/jacs.4c18308","journal-title":"J Am Chem Soc"},{"key":"2185_CR29","doi-asserted-by":"publisher","unstructured":"Kannavou M, Karali K, Katsila T, Siapi E, Marazioti A, Klepetsanis P, et al. Development and comparative in vitro and in vivo study of BNN27 mucoadhesive liposomes and nanoemulsions for nose-to-brain delivery. Pharmaceutics. 2023;15(2). https:\/\/doi.org\/10.3390\/pharmaceutics15020419.","DOI":"10.3390\/pharmaceutics15020419"},{"issue":"5","key":"2185_CR30","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/j.1471-4159.2008.05730.x","volume":"107","author":"B Poller","year":"2008","unstructured":"Poller B, Gutmann H, Kr\u00e4henb\u00fchl S, Weksler B, Romero I, Couraud P, et al. The human brain endothelial cell line hCMEC\/D3 as a human blood-brain barrier model for drug transport studies. J Neurochem. 2008;107(5):1358\u201368. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05730.x.","journal-title":"J Neurochem"},{"key":"2185_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejps.2017.02.019","volume":"101","author":"K La Papadia","year":"2017","unstructured":"Papadia K, Markoutsa E, Mourtas S, Giannou AD, La Ferla B, Nicotra F, Salmona M, Klepetsanis P, Stathopoulos GT, Antimisiaris SG. Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept. Eur J Pharm Sci. 2017;101:140\u20138. https:\/\/doi.org\/10.1016\/j.ejps.2017.02.019","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"2185_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1602\/neurorx.2.1.99","volume":"2","author":"A Schnyder","year":"2005","unstructured":"Schnyder A, Huwyler J. Drug transport to brain with targeted liposomes. NeuroRX. 2005;2(1):99\u2013107. https:\/\/doi.org\/10.1602\/neurorx.2.1.99.","journal-title":"NeuroRX"},{"key":"2185_CR33","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.jddst.2024.105954","volume":"99","author":"J Rodr\u00edguez-Castej\u00f3n","year":"2024","unstructured":"Rodr\u00edguez-Castej\u00f3n J, Plantinga JA, Beraza-Millor M, Solin\u00eds M\u00c1, Rodr\u00edguez-Gasc\u00f3n A, del Pozo-Rodr\u00edguez A, et al. Gene therapy with lipid nanoparticles for Fabry disease: Leveraging E-selectin for targeted delivery to endothelial cells. J Drug Deliv Sci Technol. 2024;99:105954. https:\/\/doi.org\/10.1016\/j.jddst.2024.105954.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"12","key":"2185_CR34","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3390\/pharmaceutics16121521","volume":"16","author":"L Catenacci","year":"2024","unstructured":"Catenacci L, Rossi R, Sechi F, Buonocore D, Sorrenti M, Perteghella S, et al. Effect of lipid nanoparticle physico-chemical properties and composition on their interaction with the immune system. Pharmaceutics. 2024;16(12):1521. https:\/\/doi.org\/10.3390\/pharmaceutics16121521.","journal-title":"Pharmaceutics"},{"issue":"9","key":"2185_CR35","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41565-025-01974-5","volume":"20","author":"S Omo-Lamai","year":"2025","unstructured":"Omo-Lamai S, Wang Y, Patel MN, Milosavljevic A, Zuschlag D, Poddar S, et al. Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape. Nat Nanotechnol. 2025;20(9):1285\u201397. https:\/\/doi.org\/10.1038\/s41565-025-01974-5.","journal-title":"Nat Nanotechnol"},{"issue":"1\u20132","key":"2185_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijpharm.2013.11.011","volume":"459","author":"A Alinaghi","year":"2014","unstructured":"Alinaghi A, Rouini MR, Johari Daha F, Moghimi HR. The influence of lipid composition and surface charge on biodistribution of intact liposomes releasing from hydrogel-embedded vesicles. Int J Pharm. 2014;459(1\u20132):30\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.11.011","journal-title":"Int J Pharm"},{"issue":"1","key":"2185_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10571-024-01522-0","volume":"45","author":"C Chang","year":"2024","unstructured":"Chang C, Weiping L, Jibing C. Exosomal MiRNA therapy for central nervous system injury diseases. Cell Mol Neurobiol. 2024;45(1):3. https:\/\/doi.org\/10.1007\/s10571-024-01522-0.","journal-title":"Cell Mol Neurobiol"},{"key":"2185_CR38","doi-asserted-by":"publisher","first-page":"108416","DOI":"10.1016\/j.clineuro.2024.108416","volume":"244","author":"A Loggini","year":"2024","unstructured":"Loggini A, Hornik J, Hornik A. The role of microRNAs as super-early biomarkers in acute ischemic stroke: A systematic review. Clin Neurol Neurosurg. 2024;244:108416. https:\/\/doi.org\/10.1016\/j.clineuro.2024.108416.","journal-title":"Clin Neurol Neurosurg"},{"issue":"50","key":"2185_CR39","doi-asserted-by":"publisher","first-page":"e40728","DOI":"10.1097\/MD.0000000000040728","volume":"103","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wang G, Tang Y. Correlation of miRNAs with infarct volume in patients with acute ischemic stroke: A systematic review. Medicine. 2024;103(50):e40728. https:\/\/doi.org\/10.1097\/MD.0000000000040728.","journal-title":"Medicine"},{"key":"2185_CR40","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.8263","author":"H Peng","year":"2019","unstructured":"Peng H, Yang H, Xiang X, Li S. \u039cicroRNA-221 participates in cerebral ischemic stroke by modulating endothelial cell function by regulating the PTEN\/PI3K\/AKT pathway. Experimental Therapeutic Med. 2019. https:\/\/doi.org\/10.3892\/etm.2019.8263.","journal-title":"Experimental Therapeutic Med"},{"issue":"2","key":"2185_CR41","doi-asserted-by":"publisher","first-page":"105489","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105489","volume":"30","author":"Y Shan","year":"2021","unstructured":"Shan Y, Hu J, Lv H, Cui X, Di W. miR-221 exerts neuroprotective effects in ischemic stroke by inhibiting the proinflammatory response. J Stroke Cerebrovasc Dis. 2021;30(2):105489. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105489.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"2185_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK-H, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92\u2013105. https:\/\/doi.org\/10.1101\/gr.082701.108.","journal-title":"Genome Res"},{"issue":"1","key":"2185_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1432-1033.2004.04389.x","volume":"272","author":"MJ Weber","year":"2005","unstructured":"Weber MJ. New human and mouse microRNA genes found by homology search. FEBS J. 2005;272(1):59\u201373. https:\/\/doi.org\/10.1111\/j.1432-1033.2004.04389.x.","journal-title":"FEBS J"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02185-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02185-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02185-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:42:06Z","timestamp":1784050926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02185-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":43,"alternative-id":["2185"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02185-8","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}